Jingyan Xue

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications

Current practices and trends of axillary surgery de-escalation and lymphedema management for breast cancer in China: a nationwide cross-sectional survey.

Current practices and trends of axillary surgery de-escalation and lymphedema management for breast cancer in China: a nationwide cross-sectional survey.

Journal: World journal of surgical oncology
Published: March 30, 2026

Peripheral Immune Dysfunction in ESCC with Lymph Node Metastasis: Implications for Preoperative Diagnosis and Prognosis.

Peripheral Immune Dysfunction in ESCC with Lymph Node Metastasis: Implications for Preoperative Diagnosis and Prognosis.

Journal: Phenomics (Cham, Switzerland)
Published: May 20, 2025

Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis.

Paired patient-derived organoids reveal transcription factor-driven epigenetic remodeling in breast cancer metastasis.

Journal: Cell stem cell
Published: May 02, 2025

Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.

Evolving Trends in Postmastectomy Breast Reconstruction With Autologous Tissues: A Large-Scale, 24-Year Retrospective Study in China.

Journal: Journal of surgical oncology
Published: May 02, 2025

A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.

A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.

Journal: International journal of surgery (London, England)
Published: April 09, 2025

Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer.

Tumor-specific MHC-II guides anthracycline exemption and immunotherapy benefit in breast cancer.

Journal: Biomarker research
Published: April 04, 2025

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway.

MSMO1 promotes chemotherapy resistance through modulation of T-MAS metabolism via PERK/elF2α/ATF4/CHOP pathway.

Journal: iScience
Published: March 19, 2025

Lipid droplet clearance inhibits esophageal cancer growth via metabolic reprogramming.

Lipid droplet clearance inhibits esophageal cancer growth via metabolic reprogramming.

Journal: Science bulletin
Published: February 10, 2025

Author Correction: R-loop-dependent promoter-proximal termination ensures genome stability.

Author Correction: R-loop-dependent promoter-proximal termination ensures genome stability.

Journal: Nature
Published: January 20, 2025

JCAD-Derived from Plasma Exosomes: Promoting Tumor Cell Progression and Predicting Poor Outcomes in Breast Cancer.

JCAD-Derived from Plasma Exosomes: Promoting Tumor Cell Progression and Predicting Poor Outcomes in Breast Cancer.

Journal: International journal of biological sciences
Published: November 27, 2024

PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer.

PPARG Activation of Fatty Acid Metabolism Drives Resistance to Anti-HER2 Therapies in HER2-Positive Breast Cancer.

Journal: International journal of biological sciences
Published: November 21, 2024

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 23, 2024
Showing 1-12 of 43

Last Updated: 09/26/2026